|
| Issue Date | Title | Author(s) |
| 5-Jan-2026 | Breath-activated nanomedicine: Ambrisentan-loaded chitosomes for pulmonary arterial hypertension | Elhabak, Mona; Shaimaa S. Ibrahim ; Farouk, Faten; Osman, Rihab ; Gehan Ali Moustafa Hussein; Elmowafy, Enas |
| 2022 | Delivery Systems of Plant-Derived Antimicrobials | Elmowafy, Enas ; El-Marakby, Eman M.; Gad, Haidy A.; Gad, Heba A. |
| Mar-2026 | Dual-action depot formulation of hyaluronic acid/poloxamer in-situ gel enclosing lavender oil-based syringic acid nanoemulsion for enhanced intra-articular treatment of osteoarthritis | Assalem, Noor; Abd-Allah, Hend; Elmowafy, Enas |
| 2022 | Hyperlipidemia control using the innovative association of lupin proteins and chitosan and α-cyclodextrin dietary fibers: food supplement formulation, molecular docking study, and in vivo evaluation | Elmowafy, Enas ; Pavoni, Lucia; Perinelli, Diego R.; Tiboni, Mattia; Casettari, Luca; Cespi, Marco; El-khouly, Ahmed; Soliman, Mahmoud E.; Bonacucina, Giulia |
| Oct-2023 | Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study | El-Derany, Marwa O; Hanna, Diana M F; Youshia, John ; Farag, Mohamed A. ; Azab, Samar S; Elmowafy, Enas |
| 2014 | Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats | Elmowafy, Enas ; Osman, Rihab ; El-Shamy, Abdel Hameed; Awad, Gehanne |
| 2-Oct-2025 | Progress in the design of ascorbic acid derivative-mediated drug delivery | Lamie, Caroline; Elmowafy, Enas ; Attia, Dalia A; Mortada, Nahed |
| 2024 | Saxagliptin beyond glycemic control: a comprehensive review | Abdrabou, Maha Mohammed; Elmowafy, Enas ; Effat, Haidy ; Azab, Samar Saad |
